| Current Price | $13.30 | Mkt Cap | $325.8M |
|---|---|---|---|
| Open | $13.94 | P/E Ratio | 0.00 |
| Prev. Close | $13.30 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $13.29 - $13.94 | Volume | 129,402 |
| 52-Wk Range | $13.29 - $15.12 | Avg. Daily Vol. | 218,381 |
| Current Price | $13.30 | Mkt Cap | $325.8M |
|---|---|---|---|
| Open | $13.94 | P/E Ratio | 0.00 |
| Prev. Close | $13.30 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $13.29 - $13.94 | Volume | 129,402 |
| 52-Wk Range | $13.29 - $15.12 | Avg. Daily Vol. | 218,381 |
The best Bull and Bear pitches based on recency and number of recommendations.
With market expectations now at rock-bottom thanks to Friday's press release, I believe now is a good time to initiate a position in Celladon.
Read the most recent pitches from players about EIGR.
Recs
oscillation
(73.50)
Submitted: 5/28/2015 9:24:56 AM :
Start Price:
$32.40
NASDAQ:EIGR Score:
-113.81
nev
Recs
treasureoaks
(< 20)
Submitted: 4/22/2015 3:54:19 PM :
Start Price:
$203.85
NASDAQ:EIGR Score:
-149.59
Oversold.
Recs
Jimbyrnes1969
(< 20)
Submitted: 4/9/2015 1:25:22 PM :
Start Price:
$252.36
NASDAQ:EIGR Score:
-152.62
I believe the Mydicar therapy is revolutionary and will help to boost Celladon's stock price much higher in relation to the market over the next 2-4 years. The Cupid2 study results being released later this month- if positive, will propel the stock 300% in the short term but the real value will be when the therapy hits the market.
Find the members with the highest scoring picks in EIGR.
|
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
|---|---|---|---|---|---|---|---|---|---|---|
| GreenAB | 33.59 | 3/20/2015 |
|
NS | $405.00 | -96.72% | +56.61% | +153.33 | 0 Comment | |
| IdahoInvestor | 33.31 | 8/17/2015 |
|
5Y | $15.75 | -15.56% | +57.55% | +73.10 | 0 Comment | |
| Playa14 | < 20 | 1/16/2018 |
|
5Y | $8.48 | +56.86% | +18.14% | +38.71 | 0 Comment | |
| hayrettin | 70.93 | 2/5/2018 |
|
5Y | $8.55 | +55.56% | +21.56% | +33.99 | 0 Comment | |
| BigDreamer | 53.92 | 1/29/2018 |
|
3Y | $8.95 | +48.60% | +15.00% | +33.60 | 0 Comment | |
| drcor | 40.29 | 1/23/2018 |
|
3M | $8.90 | +49.44% | +16.03% | +33.41 | 0 Comment | |
| skyrocket29 | 60.78 | 1/16/2018 |
|
3M | $9.10 | +46.15% | +17.54% | +28.61 | 0 Comment | |
| naughtyguy | 36.70 | 8/21/2019 |
|
5Y | $10.56 | +25.90% | +12.55% | +13.35 | 0 Comment | |
| portefeuille | 98.47 | 3/22/2018 |
|
5Y | $9.95 | +33.67% | +23.34% | +10.33 | 0 Comment | |
| jeepdrew222 | 71.72 | 8/28/2018 |
|
5Y | $12.90 | +3.10% | +13.27% | -10.17 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.
